This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Petratherm is set to commence bulk sample testwork at its Rosewood prospect, part of the Muckanippie Project in South Australia. This follows a drilling program that identified a ...

The FDA has approved the VENTANA MET (SP44) RxDx Assay as a companion diagnostic to identify individuals with non–small cell lung cancer (NSCLC) and high c-Met protein overexpression who may be ...

The global immunohistochemistry (IHC) market is experiencing steady growth, with a compound annual growth rate (CAGR) of ...

The Pathology Department of Ongole Government General Hospital (GGH) and Medical College on Monday has launched advanced ...

Foundation Medicine today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing.

Concerto Biosciences®, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, today announced the completion of the data acquisition phase of the Skin ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the addition of a full suite of ...

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

Caris is addressing these challenges by leveraging the power of MET IHC testing, which evaluates the expression of the MET protein in cancer cells. This protein is known to play a crucial role in ...

IRVING, Texas, May 12, 2025 /PRNewswire/ -- Caris Life Sciences ®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing ...